| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.02 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.02 |